Biogen (BIIB) Accumulated Expenses (2010 - 2012)

Biogen's Accumulated Expenses history runs 3 years deep, the most recent figure standing at $48.9 million for Q2 2012.

• In Q2 2012, Accumulated Expenses changed N/A year-over-year to $48.9 million; the TTM figure through Jun 2012 stood at $48.9 million (changed N/A YoY), while the FY2011 annual figure was $176.3 million, up 165.51% from the prior year.
• Accumulated Expenses was $48.9 million for Q2 2012 at Biogen, down from $108.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $176.3 million in Q4 2011 to a low of $48.9 million in Q2 2012.
• Historically, Accumulated Expenses has averaged $100.0 million across 3 years, with a median of $87.4 million in 2010.
• Biggest YoY gain for Accumulated Expenses was 165.51% in 2011; the steepest drop was 165.51% in 2011.
• A 3-year view of Accumulated Expenses shows it stood at $66.4 million in 2010, then jumped by 165.51% to $176.3 million in 2011, then plunged by 72.26% to $48.9 million in 2012.
• The last three Accumulated Expenses figures came in at $48.9 million (Q2 2012), $108.5 million (Q1 2012), and $176.3 million (Q4 2011), per Business Quant data.